Opdivo 100 mg/10 ml Concentrate for Solution for Infusion (Nivolumab)

Overview: Opdivo 100 mg/10 ml (Nivolumab)

Opdivo 100 mg/10 ml, containing the active ingredient Nivolumab, is a breakthrough immunotherapy developed by Bristol-Myers Squibb. It is classified as a human programmed death-1 (PD-1) blocking antibody, which helps the body's immune system recognize and attack cancer cells.

Mechanism and Clinical Utility

Opdivo functions by binding to the PD-1 receptor on T-cells, which prevents cancer cells from using this pathway to evade immune destruction. By restoring the immune response against the tumor, Opdivo serves as a critical therapeutic agent in managing various advanced malignancies, including melanoma, non-small cell lung cancer, and other responsive tumors.

Key Therapeutic Benefits

• PD-1 Immune Checkpoint Inhibition: Enhances the immune system's ability to identify and eliminate malignant cells.
• Advanced Immunotherapy: Provides a sophisticated treatment option that differs from traditional chemotherapy by leveraging host immunity.
• Clinical Reliability: Developed by Bristol-Myers Squibb, a leader in immunologic research, ensuring high standards of clinical efficacy and safety.
• Concentrated Formulation: Provided as a 100 mg/10 ml concentrate, allowing for precise dilution and administration by oncology professionals.

Product Details and Usage

Opdivo 100 mg/10 ml is provided in a single-vial unit. This formulation is intended for intravenous infusion within a specialized oncology setting to ensure optimal delivery and patient monitoring.

Safety and Storage Guidelines

Administration: Must be administered by healthcare professionals in a controlled oncology setting. Strict adherence to dosage and infusion protocols is required.
Storage: Keep the vial refrigerated (2°C - 8°C). Do not freeze. Protect from light by keeping the vial in its original packaging until use.
Healthcare Collaboration: Consistent coordination with your oncology care team and the specialists at El-Masry Pharmacy is essential to manage therapy and monitor for potential immune-related adverse effects.

Disclaimer: Opdivo is a specialized, prescription-only immunotherapy. Ensure you hold a valid prescription and consult with your healthcare provider before beginning any treatment plan.